Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for TARS

Stock NameTarsus Pharmaceuticals Inc
TickerTARS(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS87650L1035

Show aggregate TARS holdings

News associated with TARS

Blair William & Co. IL Trims Stake in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)
Blair William & Co. IL decreased its position in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 58.1% during the first quarter, Holdings Channel reports. The fund owned 11,416 shares of the company’s stock after selling 15,814 shares during the period. Blair William & Co. IL’s holdings in Tarsus Pharmaceuticals were worth $586,000 […] - 2025-08-11 05:52:54
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Consensus Recommendation of “Buy” from Brokerages
Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) have earned a consensus rating of “Buy” from the seven analysts that are covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation, five have given a buy recommendation and one has assigned a strong buy recommendation to […] - 2025-08-06 03:06:50
Arizona State Retirement System Buys 470 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)
Arizona State Retirement System lifted its stake in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 6.1% during the first quarter, Holdings Channel.com reports. The firm owned 8,182 shares of the company’s stock after acquiring an additional 470 shares during the period. Arizona State Retirement System’s holdings in Tarsus Pharmaceuticals were worth $420,000 […] - 2025-07-23 05:44:46
Brokerages Set Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) PT at $66.67
Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) have been assigned a consensus recommendation of “Buy” from the seven research firms that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to […] - 2025-06-20 02:36:52
GAMMA Investing LLC Purchases 13,115 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)
GAMMA Investing LLC grew its position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 36,430.6% in the first quarter, Holdings Channel reports. The fund owned 13,151 shares of the company’s stock after acquiring an additional 13,115 shares during the quarter. GAMMA Investing LLC’s holdings in Tarsus Pharmaceuticals were worth $676,000 at the end of […] - 2025-06-19 04:06:59
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 18.7% during the fourth quarter, HoldingsChannel reports. The fund owned 69,826 shares of the company’s stock after acquiring an additional 10,991 shares during the quarter. UBS AM a distinct […] - 2025-06-05 06:14:53
Nuveen Asset Management LLC Has $6.95 Million Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)
Nuveen Asset Management LLC trimmed its position in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 10.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 125,539 shares of the company’s stock after selling 15,186 shares during the quarter. Nuveen Asset […] - 2025-05-30 05:04:50
Tarsus Pharmaceuticals (NASDAQ:TARS) Raised to Buy at HC Wainwright
Tarsus Pharmaceuticals (NASDAQ:TARS – Get Free Report) was upgraded by equities research analysts at HC Wainwright to a “buy” rating in a research note issued to investors on Tuesday, Marketbeat Ratings reports. The firm currently has a $72.00 price objective on the stock. HC Wainwright’s price objective suggests a potential upside of 71.22% from the […] - 2025-05-29 02:15:10
Two Sigma Advisers LP Has $2.96 Million Stake in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)
Two Sigma Advisers LP reduced its stake in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 79.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 53,500 shares of the company’s stock after selling 202,900 shares during the quarter. Two Sigma […] - 2025-05-28 07:09:12
Two Sigma Investments LP Has $5.05 Million Stock Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)
Two Sigma Investments LP lowered its position in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 69.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 91,171 shares of the company’s stock after selling 204,832 shares during the quarter. […] - 2025-05-28 05:04:57
Tarsus Pharmaceuticals (NASDAQ:TARS) and Dyadic International (NASDAQ:DYAI) Critical Survey
Tarsus Pharmaceuticals (NASDAQ:TARS – Get Free Report) and Dyadic International (NASDAQ:DYAI – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, valuation, profitability, analyst recommendations, earnings, institutional ownership and dividends. Earnings and Valuation This table compares Tarsus […] - 2025-05-27 02:17:08
Analysts Set Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Target Price at $66.33
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) has earned an average recommendation of “Buy” from the seven research firms that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, five have issued a buy recommendation and one has issued a strong buy recommendation […] - 2025-05-26 03:08:58
Dimensional Fund Advisors LP Cuts Stock Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)
Dimensional Fund Advisors LP reduced its stake in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 15.5% during the fourth quarter, Holdings Channel reports. The institutional investor owned 341,305 shares of the company’s stock after selling 62,658 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Tarsus Pharmaceuticals were worth $18,897,000 at […] - 2025-05-08 05:25:05
The Goldman Sachs Group Forecasts Strong Price Appreciation for Tarsus Pharmaceuticals (NASDAQ:TARS) Stock
Tarsus Pharmaceuticals (NASDAQ:TARS – Get Free Report) had its target price upped by investment analysts at The Goldman Sachs Group from $46.00 to $51.00 in a report released on Monday,Benzinga reports. The firm currently has a “neutral” rating on the stock. The Goldman Sachs Group’s target price would suggest a potential upside of 9.80% from […] - 2025-05-07 02:22:52
Barclays PLC Sells 23,999 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)
Barclays PLC trimmed its holdings in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 24.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 74,664 shares of the company’s stock after selling 23,999 shares during the period. […] - 2025-04-28 05:01:20
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Sold by Legal & General Group Plc
Legal & General Group Plc trimmed its holdings in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 2.1% during the fourth quarter, Holdings Channel reports. The fund owned 26,595 shares of the company’s stock after selling 560 shares during the quarter. Legal & General Group Plc’s holdings in Tarsus Pharmaceuticals were worth $1,473,000 […] - 2025-04-27 05:42:58
Wells Fargo & Company MN Has $3.16 Million Stock Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)
Wells Fargo & Company MN raised its stake in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 44.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 57,004 shares of the company’s stock after buying an additional 17,451 shares during the period. […] - 2025-04-24 04:32:51
Geode Capital Management LLC Buys 3,014 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)
Geode Capital Management LLC lifted its position in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 0.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 838,804 shares of the company’s stock after buying an additional 3,014 shares during the quarter. Geode […] - 2025-04-15 05:00:56
Pictet Asset Management Holding SA Invests $284,000 in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)
Pictet Asset Management Holding SA bought a new stake in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) during the fourth quarter, HoldingsChannel reports. The institutional investor bought 5,130 shares of the company’s stock, valued at approximately $284,000. A number of other institutional investors and hedge funds have also recently bought and sold shares of the […] - 2025-04-11 06:24:52
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Purchased by Vanguard Group Inc.
Vanguard Group Inc. boosted its holdings in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 0.9% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 2,115,162 shares of the company’s stock after buying an additional 17,839 shares during the period. Vanguard Group Inc. owned 0.06% of Tarsus Pharmaceuticals worth $117,117,000 as […] - 2025-04-09 04:42:52
Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Gap Up After Strong Earnings
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) gapped up prior to trading on Tuesday after the company announced better than expected quarterly earnings. The stock had previously closed at $45.54, but opened at $47.44. Tarsus Pharmaceuticals shares last traded at $44.83, with a volume of 251,757 shares. The company reported ($0.60) earnings per share […] - 2025-02-27 05:10:47
Allspring Global Investments Holdings LLC Has $10.03 Million Stock Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)
Allspring Global Investments Holdings LLC cut its stake in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 14.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 181,122 shares of the company’s stock after selling 29,409 shares during the period. Allspring […] - 2025-02-19 07:08:18
Bleakley Financial Group LLC Makes New $323,000 Investment in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)
Bleakley Financial Group LLC bought a new position in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) in the fourth quarter, Holdings Channel reports. The firm bought 5,825 shares of the company’s stock, valued at approximately $323,000. A number of other large investors have also recently added to or reduced their stakes in the […] - 2025-02-12 06:57:10
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Average Rating of “Buy” from Brokerages
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) has been assigned an average recommendation of “Buy” from the seven research firms that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has given a strong buy recommendation to the […] - 2025-02-12 04:40:57
Tarsus Pharmaceuticals (NASDAQ:TARS) Given Buy Rating at Guggenheim
Guggenheim reissued their buy rating on shares of Tarsus Pharmaceuticals (NASDAQ:TARS – Free Report) in a research report released on Monday morning,Benzinga reports. A number of other equities analysts have also weighed in on the stock. Barclays boosted their price objective on shares of Tarsus Pharmaceuticals from $60.00 to $62.00 and gave the company an […] - 2025-02-11 05:09:04

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc TARS holdings

DateNumber of TARS Shares HeldBase Market Value of TARS SharesLocal Market Value of TARS SharesChange in TARS Shares HeldChange in TARS Base ValueCurrent Price per TARS Share HeldPrevious Price per TARS Share Held
2025-11-12 (Wednesday)9,588TARS holding decreased by -31USD 717,278TARS holding decreased by -10303USD 717,278-31USD -10,303 USD 74.81 USD 75.64
2025-11-11 (Tuesday)9,619USD 727,581TARS holding increased by 27414USD 727,5810USD 27,414 USD 75.64 USD 72.79
2025-11-10 (Monday)9,619USD 700,167TARS holding increased by 43670USD 700,1670USD 43,670 USD 72.79 USD 68.25
2025-11-07 (Friday)9,619USD 656,497TARS holding increased by 1539USD 656,4970USD 1,539 USD 68.25 USD 68.09
2025-11-06 (Thursday)9,619TARS holding decreased by -31USD 654,958TARS holding decreased by -3172USD 654,958-31USD -3,172 USD 68.09 USD 68.2
2025-11-05 (Wednesday)9,650TARS holding decreased by -310USD 658,130TARS holding decreased by -54010USD 658,130-310USD -54,010 USD 68.2 USD 71.5
2025-11-04 (Tuesday)9,960TARS holding decreased by -62USD 712,140TARS holding increased by 12705USD 712,140-62USD 12,705 USD 71.5 USD 69.79
2025-11-03 (Monday)10,022TARS holding decreased by -62USD 699,435TARS holding increased by 5555USD 699,435-62USD 5,555 USD 69.79 USD 68.81
2025-10-31 (Friday)10,084USD 693,880TARS holding decreased by -1513USD 693,8800USD -1,513 USD 68.81 USD 68.96
2025-10-30 (Thursday)10,084USD 695,393TARS holding increased by 14521USD 695,3930USD 14,521 USD 68.96 USD 67.52
2025-10-29 (Wednesday)10,084USD 680,872TARS holding decreased by -403USD 680,8720USD -403 USD 67.52 USD 67.56
2025-10-28 (Tuesday)10,084TARS holding increased by 93USD 681,275TARS holding increased by 238USD 681,27593USD 238 USD 67.56 USD 68.165
2025-10-27 (Monday)9,991USD 681,037TARS holding increased by 21032USD 681,0370USD 21,032 USD 68.165 USD 66.06
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TARS by Blackrock for IE00B3VWM098

Show aggregate share trades of TARS

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-12SELL-31 74.810* 49.12 Profit of 1,523 on sale
2025-11-06SELL-31 68.090* 48.67 Profit of 1,509 on sale
2025-11-05SELL-31071.95067.500 67.945USD -21,063 48.57 Loss of -6,008 on sale
2025-11-04SELL-62 71.500* 48.45 Profit of 3,004 on sale
2025-11-03SELL-6270.16067.500 67.766USD -4,201 48.33 Loss of -1,205 on sale
2025-10-28BUY9367.56068.310 68.235USD 6,346 47.91
2025-10-24SELL-3166.06069.130 68.823USD -2,134 47.70 Loss of -655 on sale
2025-10-15BUY18674.95075.010 75.004USD 13,951 46.75
2025-10-02BUY3158.77059.510 59.436USD 1,843 46.57
2025-09-30BUY6259.43059.770 59.736USD 3,704 46.44
2025-08-21SELL-3156.56056.600 56.596USD -1,754 46.16 Loss of -323 on sale
2025-07-31BUY9338.82040.490 40.323USD 3,750 46.15
2025-07-28SELL-3141.75042.250 42.200USD -1,308 46.25 Profit of 126 on sale
2025-06-30SELL-6240.51041.500 41.401USD -2,567 46.84 Profit of 337 on sale
2025-06-25SELL-3140.20042.000 41.820USD -1,296 46.97 Profit of 160 on sale
2025-06-20SELL-6240.65041.300 41.235USD -2,557 47.11 Profit of 364 on sale
2025-05-23BUY3142.98043.230 43.205USD 1,339 47.92
2025-05-19SELL-3145.01045.170 45.154USD -1,400 48.05 Profit of 90 on sale
2025-05-15SELL-9343.50043.950 43.905USD -4,083 48.13 Profit of 393 on sale
2025-05-12SELL-3144.20046.250 46.045USD -1,427 48.27 Profit of 69 on sale
2025-05-09SELL-3144.76047.320 47.064USD -1,459 48.30 Profit of 38 on sale
2025-04-30SELL-3151.91052.100 52.081USD -1,615 48.30 Loss of -117 on sale
2025-04-24SELL-6249.97050.500 50.447USD -3,128 48.23 Loss of -138 on sale
2025-04-17SELL-3149.25050.300 50.195USD -1,556 48.17 Loss of -63 on sale
2025-04-15SELL-9349.12049.800 49.732USD -4,625 48.15 Loss of -147 on sale
2025-04-14SELL-9348.72048.725 48.724USD -4,531 48.14 Loss of -54 on sale
2025-04-09SELL-12445.87046.310 46.266USD -5,737 48.23 Profit of 244 on sale
2025-04-07SELL-21747.49049.040 48.885USD -10,608 48.28 Loss of -131 on sale
2025-04-04SELL-31047.02048.800 48.622USD -15,073 48.30 Loss of -101 on sale
2025-03-31BUY3151.37051.630 51.604USD 1,600 48.21
2025-03-19SELL-6249.55049.730 49.712USD -3,082 47.93 Loss of -110 on sale
2025-03-14SELL-18648.09048.230 48.216USD -8,968 47.96 Loss of -48 on sale
2025-03-13SELL-6246.47048.955 48.707USD -3,020 47.98 Loss of -45 on sale
2025-03-12SELL-1,05447.10049.900 49.620USD -52,299 47.99 Loss of -1,714 on sale
2025-03-07SELL-6246.47046.770 46.740USD -2,898 48.08 Profit of 83 on sale
2025-03-06SELL-9343.57044.390 44.308USD -4,121 48.15 Profit of 357 on sale
2025-03-03SELL-3142.72044.750 44.547USD -1,381 48.36 Profit of 118 on sale
2025-02-28SELL-45,55244.48044.810 44.777USD -2,039,682 48.42 Profit of 165,894 on sale
2025-02-26SELL-15142.56043.760 43.640USD -6,590 48.60 Profit of 749 on sale
2025-02-25SELL-45341.29047.630 46.996USD -21,289 48.73 Profit of 784 on sale
2025-02-18BUY75550.85051.280 51.237USD 38,684 48.75
2025-02-13BUY15152.23053.220 53.121USD 8,021 48.62
2025-02-12BUY15152.33052.970 52.906USD 7,989 48.54
2025-02-11BUY45351.22052.005 51.927USD 23,523 48.49
2025-02-06BUY1,35953.32056.960 56.596USD 76,914 48.21
2025-01-27BUY15151.45054.080 53.817USD 8,126 47.10
2024-12-30BUY75554.70057.140 56.896USD 42,956 46.51
2024-12-06BUY60451.79052.020 51.997USD 31,406 46.06
2024-12-05BUY15150.32051.730 51.589USD 7,790 45.92
2024-12-04BUY75551.64052.130 52.081USD 39,321 45.71
2024-11-29BUY75552.45052.650 52.630USD 39,736 45.07
2024-11-27BUY60450.84051.460 51.398USD 31,044 44.56
2024-11-26BUY15149.66051.250 51.091USD 7,715 44.33
2024-11-25SELL-10,54348.32049.090 49.013USD -516,744 44.14 Loss of -51,346 on sale
2024-11-21BUY91546.40047.600 47.480USD 43,444 43.81
2024-11-20BUY54946.58047.370 47.291USD 25,963 43.65
2024-11-18BUY2,19644.63046.790 46.574USD 102,277 43.39
2024-11-12BUY1,46447.57049.623 49.418USD 72,348 43.11
2024-11-08BUY91549.42049.900 49.852USD 45,615 42.66
2024-11-07BUY2,73046.79047.400 47.339USD 129,235 42.34
2024-11-06BUY36446.80051.590 51.111USD 18,604 41.97
2024-10-31BUY18244.49045.250 45.174USD 8,222 40.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TARS

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19252,8010426,16659.3%
2025-09-18137,9760230,32459.9%
2025-09-17350,4365543,37964.5%
2025-09-16169,76223341,91749.7%
2025-09-15188,2200351,01153.6%
2025-09-12173,82419536,80232.4%
2025-09-11254,1690587,02943.3%
2025-09-10130,04921,726202,27364.3%
2025-09-0981,0810152,61653.1%
2025-09-08127,26213,834268,32947.4%
2025-09-05111,5980279,26040.0%
2025-09-04157,7406,413224,74570.2%
2025-09-0372,2421,200191,62937.7%
2025-09-02219,4490325,87467.3%
2025-08-2962,1330140,05044.4%
2025-08-2850,5410159,80831.6%
2025-08-2736,919092,54339.9%
2025-08-2663,6280154,05841.3%
2025-08-2572,1090148,87248.4%
2025-08-2280,7860201,82940.0%
2025-08-2173,6460231,97931.7%
2025-08-2093,401891221,73342.1%
2025-08-1942,4180137,19730.9%
2025-08-18116,54120,164304,69938.2%
2025-08-15133,688400335,13339.9%
2025-08-1481,791328173,47347.1%
2025-08-13119,9020340,39235.2%
2025-08-12113,5280262,06743.3%
2025-08-11247,112200586,91942.1%
2025-08-08164,5940266,10561.9%
2025-08-07425,029300765,61555.5%
2025-08-06173,64439252,86868.7%
2025-08-0589,0195111,44379.9%
2025-08-04104,35720207,09750.4%
2025-08-01273,9720370,17874.0%
2025-07-31170,4130271,10162.9%
2025-07-3092,2280317,92929.0%
2025-07-29142,6840285,14150.0%
2025-07-28123,43831191,76464.4%
2025-07-25123,025336162,52075.7%
2025-07-24122,48510171,35071.5%
2025-07-23115,7910149,65377.4%
2025-07-2284,08910133,73162.9%
2025-07-21196,108151244,90580.1%
2025-07-18290,801482509,80457.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.